Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Winkelmann

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Haematologica|February 17, 2022
Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignanciesDavid M Cordas Dos Santos, Kai Rejeski, Michael Winkelmann, et al.
Cytotherapy|April 13, 2023
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Discover Oncology|November 19, 2025
Feasibility of different meningioma delineation approaches on [<sup>18</sup>F]SiTATE PET/CT imagingSophie Carina Kunte, Lena M Unterrainer, Simon Lindner, et al.
Emerging Infectious Diseases|August 2, 2003
Acute flaccid paralysis and West Nile virus infectionJames J Sejvar, A Arturo Leis, Dobrivoje S Stokic, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2023
Metabolic patterns on [<sup>18</sup>F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatmentAdrien Holzgreve, Julian Taugner, Lukas Käsmann, et al.
European Radiology|August 25, 2023
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patientsFreba Grawe, Franziska Blom, Michael Winkelmann, et al.
European Radiology|March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patientsFreba Grawe, Ricarda Ebner, Thomas Geyer, et al.
Cancer Immunology Research|April 11, 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell TherapyKai Rejeski, David M Cordas Dos Santos, Nathan H Parker, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitorsSebastian Mönch, Maurice M Heimer, Michael Winkelmann, et al.
The New England Journal of Medicine|March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid SyndromeAdrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Haematologica|February 17, 2022
Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignanciesDavid M Cordas Dos Santos, Kai Rejeski, Michael Winkelmann, et al.
Cytotherapy|April 13, 2023
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Discover Oncology|November 19, 2025
Feasibility of different meningioma delineation approaches on [<sup>18</sup>F]SiTATE PET/CT imagingSophie Carina Kunte, Lena M Unterrainer, Simon Lindner, et al.
Emerging Infectious Diseases|August 2, 2003
Acute flaccid paralysis and West Nile virus infectionJames J Sejvar, A Arturo Leis, Dobrivoje S Stokic, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2023
Metabolic patterns on [<sup>18</sup>F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatmentAdrien Holzgreve, Julian Taugner, Lukas Käsmann, et al.
European Radiology|August 25, 2023
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patientsFreba Grawe, Franziska Blom, Michael Winkelmann, et al.
European Radiology|March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patientsFreba Grawe, Ricarda Ebner, Thomas Geyer, et al.
Cancer Immunology Research|April 11, 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell TherapyKai Rejeski, David M Cordas Dos Santos, Nathan H Parker, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitorsSebastian Mönch, Maurice M Heimer, Michael Winkelmann, et al.
The New England Journal of Medicine|March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid SyndromeAdrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Pageof 5